Ortho Dermatologics

Apr 29, 2020

FDA Approves Ortho Dermatologics' Labeling For JUBLIA® (efinaconazole) Topical Solution, 10%, In Patients As Young As Six Years Old

Aug 01, 2019

Bausch Health Expands Dermatology Cash-Pay Prescription Program to Walgreens Stores Nationwide

Feb 28, 2019

Ortho Dermatologics To Present New Analyses At The American Academy Of Dermatology Annual Meeting

Oct 02, 2018

Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On Bryhali(TM)* (Halobetasol Propionate) Lotion, 0.01% In The Journal Of Drugs In Dermatology

Aug 15, 2018

Ortho Dermatologics Resubmits U.S. New Drug Application For DUOBRII(TM) (halobetasol propionate and tazarotene) Lotion

Aug 08, 2018

Ortho Dermatologics Announces 2018 Aspire Higher Scholarship Recipients

Jun 18, 2018

FDA Issues Complete Response Letter For DUOBRII(TM) (Halobetasol Propionate and Tazarotene) Lotion

Apr 09, 2018

Ortho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII(TM) In The Journal of the American Academy of Dermatology

Sep 05, 2017

Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-118

Jul 27, 2017

Valeant Announces U.S. Launch of SILIQ(TM) (brodalumab) Injection